Ceftriaxone Sodium USP 500mg (IV/IM)
Dicephin is indicated for the treatment of the following infections when caus ed by susceptible organisms: lower respiratory tract infections, skin and skin structure infections, urinary tract infections, uncomplicated gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, bone and joint infections, meningitis and surgical prophylaxis.
Ceftriaxone Sodium USP 500mg (IV/IM)
Dicephin is indicated for the treatment of the following infections when caus ed by susceptible organisms: lower respiratory tract infections, skin and skin structure infections, urinary tract infections, uncomplicated gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, bone and joint infections, meningitis and surgical prophylaxis.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.